Sekisui Chemical Co., Ltd. (TYO:4204)
Japan · Delayed Price · Currency is JPY 2,359.50
-9.00 (-0.38%)
May 1, 2026, 3:30 PM JST
Sekisui Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,309,281 | 1,297,754 | 1,256,538 | 1,242,521 | 1,157,945 | |
Revenue Growth (YoY) | 0.89% | 3.28% | 1.13% | 7.30% | 9.60% |
Cost of Revenue | 885,102 | 877,147 | 864,343 | 865,281 | 801,994 |
Gross Profit | 424,179 | 420,607 | 392,195 | 377,240 | 355,951 |
Selling, General & Admin | 317,701 | 251,775 | 239,679 | 230,198 | 215,806 |
Research & Development | - | 44,249 | 41,701 | 40,471 | 37,010 |
Operating Expenses | 317,701 | 312,655 | 297,795 | 285,574 | 267,071 |
Operating Income | 106,478 | 107,952 | 94,400 | 91,666 | 88,880 |
Interest Expense | -1,442 | -1,038 | -1,103 | -871 | -774 |
Interest & Investment Income | 5,508 | 5,394 | 5,457 | 4,888 | 4,357 |
Earnings From Equity Investments | 2,442 | -1,092 | 843 | 2,254 | 108 |
Currency Exchange Gain (Loss) | 4,749 | -411 | 6,958 | 5,195 | 4,816 |
Other Non Operating Income (Expenses) | -520 | 2,079 | -210 | 1,815 | -387 |
EBT Excluding Unusual Items | 117,215 | 112,884 | 106,345 | 104,947 | 97,000 |
Gain (Loss) on Sale of Investments | 13,643 | 14,055 | 11,458 | -130 | 25,909 |
Gain (Loss) on Sale of Assets | -2,583 | -2,251 | -1,773 | -2,174 | -1,544 |
Asset Writedown | -23,302 | -4,714 | -4,554 | -3,148 | -51,508 |
Other Unusual Items | 50 | -1 | 1 | -2 | - |
Pretax Income | 105,023 | 119,973 | 111,477 | 99,493 | 69,857 |
Income Tax Expense | 27,672 | 35,867 | 32,424 | 28,726 | 31,098 |
Earnings From Continuing Operations | 77,351 | 84,106 | 79,053 | 70,767 | 38,759 |
Minority Interest in Earnings | -2,177 | -2,181 | -1,123 | -1,504 | -1,692 |
Net Income | 75,174 | 81,925 | 77,930 | 69,263 | 37,067 |
Net Income to Common | 75,174 | 81,925 | 77,930 | 69,263 | 37,067 |
Net Income Growth | -8.24% | 5.13% | 12.51% | 86.86% | -10.78% |
Shares Outstanding (Basic) | 411 | 418 | 425 | 435 | 446 |
Shares Outstanding (Diluted) | 411 | 418 | 425 | 435 | 446 |
Shares Change (YoY) | -1.60% | -1.55% | -2.38% | -2.38% | -1.39% |
EPS (Basic) | 182.70 | 195.93 | 183.48 | 159.19 | 83.17 |
EPS (Diluted) | 182.70 | 195.93 | 183.48 | 159.19 | 83.17 |
EPS Growth | -6.75% | 6.78% | 15.26% | 91.41% | -9.52% |
Free Cash Flow | -22,480 | 61,127 | 60,562 | 26,869 | 68,026 |
Free Cash Flow Per Share | -54.63 | 146.19 | 142.59 | 61.75 | 152.63 |
Dividend Per Share | 80.000 | 79.000 | 74.000 | 59.000 | 49.000 |
Dividend Growth | 1.27% | 6.76% | 25.42% | 20.41% | 4.25% |
Gross Margin | 32.40% | 32.41% | 31.21% | 30.36% | 30.74% |
Operating Margin | 8.13% | 8.32% | 7.51% | 7.38% | 7.68% |
Profit Margin | 5.74% | 6.31% | 6.20% | 5.57% | 3.20% |
Free Cash Flow Margin | -1.72% | 4.71% | 4.82% | 2.16% | 5.88% |
EBITDA | 164,602 | 161,708 | 147,072 | 144,072 | 137,584 |
EBITDA Margin | 12.57% | 12.46% | 11.71% | 11.59% | 11.88% |
D&A For EBITDA | 58,124 | 53,756 | 52,672 | 52,406 | 48,704 |
EBIT | 106,478 | 107,952 | 94,400 | 91,666 | 88,880 |
EBIT Margin | 8.13% | 8.32% | 7.51% | 7.38% | 7.68% |
Effective Tax Rate | 26.35% | 29.90% | 29.09% | 28.87% | 44.52% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.